Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 320

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 320
---
Accrued liabilities consisted of the following as of March
31, 2025 and December 31, 2024:

|                                               |     | March 31,   
 2025        
 (Successor) |         |     | December 31, 
 2024         
 (Successor)  |           |
|:----------------------------------------------|:----|:------------|--------:|:----|:-------------|----------:|
| Employee-related liabilities                  |     | $           |  61,078 |     | $            |   244,302 |
| Accrued franchise taxes                       |     |             |  78,448 |     |              |    78,448 |
| Accrued legal expenses                        |     |             |       - |     |              |   593,825 |
| Insurance payable                             |     |             | 275,133 |     |              |         - |
| Penalty for late S-1 filing and effectiveness |     |             |  55,000 |     |              |    55,000 |
| Accrued consulting and professional services  |     |             |       - |     |              |   941,600 |
|                                               |     | $           | 469,659 |     | $            | 1,913,175 |

NOTE 7 – LEASES

As of March 31, 2025 and
December 31, 2024, the Company holds a lease for laboratory and office space. The lease has escalating contractual rent and
variable rent components and the Company elected to separate the contractual and variable elements for valuing the operating lease liability
and right-to-use asset. The lease does not have any options for extension or expansion.

|                               |     |   |                      For the 
 three months ended March 31, 
                         2025 
                  (Successor) |     |   |        For the 
    period from 
   February 14, 
   2024 through 
 March 31, 2024 
    (Successor) |     |   |       For the 
   period from 
    January 1, 
  2024 through 
  February 13, 
          2024 
 (Predecessor) |
|:------------------------------|:----|:--|-----------------------------:|:----|:--|---------------:|:----|:--|--------------:|
| Operating leases:             |     |   |